Abstract: In some hospitals, clinical pharmacists review the medication to find drug-related problems (DRPs) in acutely admitted patients. We aimed to identify the nature of identified DRPs and investigate factors of potential importance for the clinical implementation of pharmacist suggestions. In 100 randomly selected medication review (MR) notes, we retrospectively evaluated the clinical implementation and classified (1) timing and communication of the review; (2) DRPs and related suggestions for the physician; and (3) DRPs' potential clinical relevance to patients as 'beneficial', 'somewhat beneficial', 'no relevance' or 'other relevance'. Of 327 DRPs (0-13 DRPs per patient), 42% were implemented. The clinical implementation was higher if the MR note was made prior to (instead of after) the physician's admission, and even higher if the suggestions were communicated verbally (instead of only in writing) to the physicians (44% versus 79%, p < 0.05). The clinical relevance of the DRPs was either 'beneficial' (16%), 'somewhat beneficial' (43%), 'no relevance' (22%) or 'other relevance' (19%). The 'beneficial' DRPs had a higher clinical implementation (53%) than 'no relevance' (34%) (p < 0.05). The most frequently implemented suggestions were based on DRPs concerning 'indication for drug treatment not noticed', 'inappropriate drug form' and 'drug dose too low', with implementation rates of 83%, 67% and 63%, respectively. In our sample, the pharmacist's MR suggestions were only implemented by physicians in 42% of the cases, but review prior to physician contact and verbal communication of the suggestions, higher clinical relevance and specific types of DRPs were associated with a higher implementation rate.
Ideally, there is substantial benefit to gain from performing systematical, critical reviews of hospitalized patients' medication. Nonetheless, a benefit of medication reviews (MRs) in terms of reduced morbidity and mortality has not been consistently demonstrated in clinical trials [1, 2] . This could be due to uncertainties about which patient population should receive MR, the timing of the MR, the quality of the review (e.g. using explicit criteria or based solely on qualifications of the reviewer) or lack of subsequent implementation of the MR suggestions. Particularly, the acceptance and implementation of suggestions by physicians have varied a great deal between studies [3, 4] and keeping implementation rate high should be a focus area for anyone attempting to maximize the clinical benefit of the MR. Despite the lack of certainty as to which method for MR works best, MRs performed by pharmacists or physicians have been implemented as standard procedure in hospital departments in many European countries.
The aim of this study was to critically evaluate one model of pharmacist-led MR in order to improve the intervention and future clinical trials in this area. We aimed to identify the nature and distribution of drug-related problems (DRPs) and how physicians evaluate the clinical relevance of pharmacists' suggestions based on these. Furthermore, we explored these and other factors of importance for the clinical use of these suggestions in the short term, that is implementation by physicians.
Methods
Description of the pharmacist-led MR. Since 2013, pharmacists have been performing MR in the acute medical ward at Bispebjerg Hospital, a 625-bed hospital located in Copenhagen. This acute medical ward has no surgical patients but sees patients with medical illnesses within the specialities cardiology, endocrinology, medical gastroenterology and respiratory medicine. Ten pharmacists (with 2-10 years of clinical experience at the time of study) perform MR all weekdays from 8 a.m. to 6 p.m. for patients over 50 years using five or more medicines. A 'MR note' written by the pharmacist documents the MR in the patients' electronic medical records. The MR contains (1) a precise medication list (medication reconciliation) and (2) a critical review of the medication list with suggestions for change in prescriptions (referred to as DRPs) for the physicians to act upon if deemed clinically relevant.
To provide the first part of the MR, the so-called medication reconciliation, the pharmacist gathers the best possible medication history including information on medication adherence from multiple sources: if possible, always through the Danish prescription medicine register (a national register of all prescription drugs redeemed by Danish citizens at a pharmacy within the last 2 years), conversation with the patients, and patients' own medication list. If uncertainty still exists, then relevant relatives, general practitioners (GPs), home care or nursing homes, etc., are contacted by telephone to further substantiate the medication list.
For the second part of the MR, the pharmacist critically reviews each patient's medication by evaluating dose regimens, choice of medical therapy, side effects, drug-drug interactions, prescribing errors and contraindications. The pharmacist also considers laboratory data and makes recommendations to address patient-specific characteristics, for example impaired kidney or liver function, if relevant. This part also includes a conversation with the patient about adverse events and adherence to medication regimens. The recommendations are always communicated to the attending hospital physician as a written note in each patient's electrical medical record, and if possible, also verbally.
Data extraction. In 2014, the pharmacists produced a total of 1930 pharmacist 'review notes', corresponding to 25% of all admissions to the acute medical ward. We used the website www.random.org to randomly select 10 MR notes per month from January to October 2014 and reviewed the related patients' medical history and laboratory results. We extracted data on DRPs, time spent on MR, the clinical relevance of each DRP, whether the pharmacist MR note was made before or after the physician's admission note and whether or not the pharmacists had communicated relevant information regarding the patient's medication to the physician verbally (in addition to the MR note in the patient's medical record).
Drug-related problems. For each MR note, we recorded the number, type and cause of DRPs noted by the pharmacist. The DRPs were categorized according to a modified version of 'The PCNE Classification V 6.2' [5] . All DRPs were categorized as either DRPs with 'treatment effectiveness', 'adverse reactions' or a separate novel category called 'sector transitions', covering DRPs due to transitions, for example between primary and secondary (hospital) sectors.
According to this, the MR level in this study was PCNE Type 3 'advanced MR' because the pharmacist had access to medication history, patient information and clinical information (the patient's electronic medical record and laboratory results), or PCNE Type 2A 'intermediate MR', if all clinical information was not available at admission [6] .
Clinical/patient relevance. Three physicians (a specialist in internal medicine and clinical pharmacology (JS), a specialist in clinical pharmacology (MC), and a junior doctor with 3 years of clinical training in internal medicine) assessed the clinical significance of each DRP. The assessments were performed according to a modified version of the method described by Overhage et al. [7] . This method (appendix 1) can be used to rate the severity and value of hospital pharmacists' interventions and thus provide a measure of the clinical relevance of these interventions to patients. We simplified the method and the physicians attributed the practical, clinical significance of the suggestions conveyed with each DRP to five categories of clinical relevance (A: Highly beneficial, B: Beneficial, C: Somewhat beneficial, D: No relevance and E: Other relevance). Thus, each physician retrospectively assigned clinical relevance to each DRP based on the patient's entire medical record, including laboratory values and electronic prescribing system. The physicians were instructed to refrain from worst-case scenarios and, as the assessments were based on an acute hospital admission, to consider only the clinical relevance to the patient on the relatively short term. Any disagreement between physicians was solved by discussion and if necessary involvement of a fourth physician [specialized in internal medicine and clinical pharmacology (HRC)] as arbiter.
Clinical implementation. For each DRP suggestion, we examined whether it was 'implemented' in patient care defined as the presence of at least one of the following two situations: (1) the DRP suggestions were implemented in the electronic prescribing system and (2) the proposed amendments were communicated in the discharge summary to the GP for him to act upon. In addition to these two instances, a DRP could be 'commented', but not 'implemented' if the content in the MR note only was mentioned by physicians in the medical chart. Lastly, we defined MR notes that were neither 'implemented' nor 'commented' as 'unused'. Thus, by definition, some DRP suggestions categorized as 'unused' may have been read without leading to changes in prescription or mentioning in the patient's medical record or discharge summary.
Data analysis. We entered patient data, clinical pharmacist intervention data and clinical relevance data into a spreadsheet (MS Excel version 2010). Continuous data were reported using descriptive statistics. To compare dichotomous variables and proportions, we used Fisher's exact test or chi-square analysis and test for trend. A pvalue < 0.05 was considered statistically significant. Statistical analyses were performed with GraphPad Prism, version 6.01 (GraphPad Software, La Jolla, CA, USA).
Results
Specific characteristics of the study sample are summarized in table 1. The patients used an average of nine medications (ranging from 3 to 19 medications).
In total, 327 DRPs were registered, with a median of three DRPs per patient (ranging from 0 to 13 DRPs per patient). Nine patients had no DRPs. Table 2 shows the medicines most frequently involved in DRPs. Thirty percentage were in ATC drug group A, mainly drugs for peptic ulcer and gastro-oesophageal reflux disease, laxatives, vitamins and antidiabetic drugs; 22% were in ATC group N, most frequently opioids and antipsychotics; and 18% were in ATC group C, most frequently diuretics and agents acting on the renin-angiotensin system. Clinical/patient relevance of the registered DRPs.
The clinical/patient relevance of each DRP was categorized into five categories (A-E). Table 3 shows that 0.3% were categorized as 'highly beneficial', 16% were categorized as 'beneficial', 43% of the DRPs were categorized as 'somewhat beneficial' and 22% were categorized as having 'no relevance'. The category 'other relevance' accounts for 19% of the DRPs and covers mainly suggestions about substitution of drugs to the drugs available in Hospital Formulary as well as DRPs with possible adverse significance to patients.
The clinical implementation of the MR notes.
A specification of the assessments of clinical implementation of each DRP is available in appendix 2. Of all DRPs identified in the MR notes, 42% were implemented by the physician. In another 6% of the cases, the physician commented on the DRP in the patient's medical record but did not follow the pharmacist's recommendation. The remaining 52% of the DRPs were classified as 'unused'.
Timing and communication.
The first part of the pharmacist note contained the medication reconciliation, and suggestions based on this part of the MR were implemented in 60% of cases.
If medication reconciliation suggestions, besides being present in the patient's medical record as a MR note, also were delivered verbally to the physician, the rate of implementation was 15-22 (absolute) percentage points higher ( fig. 1 ). Likewise, if the pharmacist notes were prepared before the physician prepared his or her admission note, the rate of acceptance was 17-23 (absolute) percentage points higher ( fig. 1 ) (p < 0.03 for comparison between groups I and IV).
DRPs and clinical relevance. The type and clinical relevance of DRPs affected the clinical implementation. Higher (i.e. more beneficial) clinical relevance led to more frequent implementation. Thus, the DRP suggestions either led to a change in prescription or were The most commonly identified type of DRPs was discrepancies between medication taken at home and prescribed medication at admission to hospital (35% of all DRPs), and of suggestions based on these, more than 50% were implemented.
The DRPs classified by the PCNE classification as 'indication for drug treatment not noticed',' 'dose too low' and 'inappropriate drug form' were evaluated as clinical relevant to patients (i.e. categorized as 'highly beneficial', 'beneficial' or 'somewhat beneficial') in 100%, 75% and 67% of cases, respectively, and had a high implementation rate (i.e. led to a change in prescription or communicated in the discharge summary to GP) of, respectively, 83%, 63% and 67%.
We found DRPs regarding adherence in 22% of the patients and these were in general rated as having clinical/ patient relevance (i.e. categorized as 'beneficial' or 'somewhat beneficial').
Time consumption.
The pharmacists spent an average of 54 min. (range 17-125) on the preparation of the MR note, including gathering medication history, patient interview, performing the MR and typing in the patient's medical record. On average, 9 min. was used for gathering information (from, i.e., primary care, local pharmacy or GPs), 11 min. was spent talking to patients about their medication use and 27 min. was used on the MR and typing in the patient's medical record.
Discussion
This study examined the types and relevance of the DRPs identified by pharmacists during MR in an acute medical ward in Denmark. We report some issues worth considering. In our study, the physicians only implemented 42% of the suggestions based on DRPs addressed by the pharmacists. This is within the range of 40-90%, which has been reported in other studies [3, [8] [9] [10] [11] . Nevertheless, it means that more than half of For specification of categories; appendix 1.
suggestions were not implemented; and to our surprise, our data showed that even for the DRP suggestions rated 'beneficial' (see table 3 ) by physicians, only 53% (mean value) were implemented. In principle, there could be many reasons for the relatively low implementation rate in our study sample: Physicians focusing on the primary reason for admission, a heavy workload, unawareness of the pharmacist note and irrelevant pharmacist suggestions are likely causes.
Interestingly, the clinical implementation of the pharmacist medication reconciliation seems to be influenced by the timing and communication of the pharmacist MR. If the pharmacist note is prepared before the physician sees the patient, it is more frequently used. The physician may implement the pharmacist note as an auxiliary tool when admitting the patient, which may reduce physician time and limit the risk of sector transition errors. We also found that the clinical implementation of the medicine reconciliation was higher when the pharmacist, besides writing the note, also verbally presented the pharmacist note to the physician (thereby securing awareness of the pharmacist note). A beneficial effect of face-to-face communication is also corroborated by studies, showing that subsequent implementation by physicians is 69-90%, when proposed interventions have been communicated verbally [8, [10] [11] [12] , and 39-70% when only communicated as a written note [2, 4, 8] . In a French study, Bedouch et al. also found a significantly higher acceptance rate (defined as modification of the prescription according to the pharmacist intervention) for oral communication (79%) compared to written communication (24%) [10] .
Besides way of communication, several other factors have been reported by others to influence the clinical implementation of pharmacist notes. Status of the physician, for example, junior or senior [10] , type of DRP [9, 10] , standardized entry A drug-related problem (DRP) is implemented when the DRP suggestion leads to that a physician changes the prescription and/or communicates the suggestion in the discharge summary to the general practitioner. Primary note is when the pharmacist medication review note is made prior to the physician's admission note; secondary note is when pharmacist notes are made after the physician's admission note. DRP suggestions are always presented in writing but can also be presented verbally. The p-value designates the comparison between groups I and IV with Fisher's exact test. of interventions directly into the prescription system [8, 13] , degree of pharmacist ward integration [3, 9] and degree of the pharmacist's experience [14] could all be of importance. We did not look at these factors. We used a highly standardized entry into the electronic medical chart (see appendix 3), but changes were not made directly into the prescribing system. The fact that only 42% of the DRPs addressed by the pharmacists were implemented in our sample clearly raises questions as to whether it is possible to increase the implementation.This could be by better ward integration of the pharmacist, upgrade in the clinical skills, or ensuring availability of the MR for the physician prior to the admission note.
The pharmacists used an average of 54 min. on the MR note. This is comparable to the 60 min. found in a Swedish study where pharmacists conducted MR in a similar way [15] . According to Coane et al. [16] , who have discussed the National Institute for Health and Care Excellence (NICE) recommendations relating to MR [17] , a MR is time-consuming (i.e. they suggest 20 min. of patient-facing time) in order to be effective. Further they state that time invested is usually compensated for in drug cost savings and that, when undertaken by a pharmacist, allows more time for the physician for their daily workload [16, 18] .
Another important issue is that the significant number of the registered DRPs due to sector transition errors (i.e. more than one-third of all DRPs) that would, without the presence of a pharmacist, have led to patients being either under-or over-prescribed. A large proportion (47%) of the sector transition DRPs were considered clinically relevant (i.e. 'beneficial' or 'somewhat beneficial'). The finding of transitions errors to be frequent is similar to what is described in other studies [4, [8] [9] [10] . Nevertheless, the extent was somewhat surprising considering the fact that problems with reconciling medication lists have been a major focus in the past decade, and electronic prescribing systems have been introduced in Denmark partly to alleviate these problems. These sector transition DRPs likely occur because the hospital physicians cannot (or do not have time to) find the correct information regarding the patient's medication use and GPs do not update the electronic system. Our study highlights that there is still room for improvements in the communication about medication use between the hospital and the primary caregivers, that is primarily GPs. One way to improve medication communication from hospital to the GP may be to send structured patient discharge information to the GP [19] .
Of all the DRP suggestions, 22% were evaluated as having 'no relevance' (category D). Some of these DRPs will contain general, useful knowledge for the GP that is just not applicable to the specific patient (see appendix 1). It would be worth looking into how to reduce the amount of DRPs with no clinical relevance, that is by investigating what kind of information is demanded by the physicians (or by upgrading the clinical skills of the pharmacists).
A total of 19% (N = 62) of DRP suggestions were classified as 'other relevance'. Of these, more than one half (N = 33) were simple analogue substitutions of medicines to comply with hospital Formulary, which is one of the assigned tasks for the hospital pharmacist performing MR. Seven percentage of all DRPs were categorized as 'adverse significance' to patients if implemented. Most of the DRPs with possible adverse significance occurred because of sector transitions, and some of these DRPs were likely caused by lack of relevant information at the time of the MR (e.g. about comorbidities, laboratory data suggesting renal impairment) related to the current admission. Furthermore, these DRPs were not graded regarding clinical severity and generally were not of major clinical relevance (e.g. a DRP suggestion to change a medication dose that is actually appropriate); and although 23% of the suggestions were implemented, none had caused patient harm at the time of evaluation. Nevertheless, their existence indicates that physicians cannot uncritically implement all suggestions that are based on pharmacist-identified DRPs; and an improvement within this area may substantially increase the clinical relevance and implementation rate of pharmacist suggestions. This notion is supported by a study from 2013 showing that clinical relevance of suggestions is the most important factor for implementation of medication counselling [20] .
Our study has some limitations. Firstly, the retrospective nature of this study precludes establishing causal relationships. It is possible that knowing the clinical course after the MR might have affected the interpretation of clinical relevance. However, it may also be a strength that the entire clinical course is known when evaluating the clinical relevance. Secondly, our results are based on a fairly limited sample at a single centre, possibly limiting the external validity. Despite this limitation, it is possible that our results may help similar services to gain impact across Europe, as published evidence from Sweden [11] and the Netherlands [21] indicates many similarities among pharmacist services across the European countries, that is in terms of the patient population, medication use and the DRPs found.
In conclusion, our study shows that an average 42% of DRPs addressed by pharmacists were implemented and that the type of DRPs, the clinical relevance of pharmacists' suggestions and the timing and communication of the suggestions seem to affect the implementation rate. The implementation rate was highest when the MR notes were prepared before the physician made the admission note and communicated not only verbally to the physician, but also in writing in the patients' medical record. Likewise, certain types of DRPs and DRP suggestions that were rated clinically beneficial were associated with a higher implementation.
Our results confirm that pharmacists in an acute ward are able to assist with medication reconciliation/review and reduce the number clinically relevant DRPs. Furthermore, our results point to possible ways of improving the clinical impact of pharmacist-led MR, for example by verbal communication and by focusing on DRPs with clinical relevance.
non-compliance of drugs with unclear indication or 'symptomatic' indication such as non-opioid pain medication, laxatives without constipation, and bronchodilator treatment without respiratory symptoms). 
